BridgeMD
New treatment option for Breast Cancer
Official title Multicenter Cardiac Decision Impact Study in People With Breast Cancer
ClinicalTrials.gov ID: NCT07703033
What this study is testing
- What it's testing
- Background: Breast cancer is the most common cancer in women, and advances in early detection and treatment have led to steadily improved survival rates. Today, nearly 80% of breast cancer survivors are over 50 years of age.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 and older
You may be able to join if
- diagnosed with breast cancer or ductal carcinoma in situ
- Planned for radiotherapy
- From 35 years of age onwards
You likely can't join if
- Pregnancy
- Breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Copenhagen, Denmark
- München, Germany
- Amsterdam, Netherlands
- Utrecht, Netherlands
- Lisbon, Portugal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Copenhagen, Denmark; München, Germany; Amsterdam, Netherlands; Utrecht, Netherlands; Lisbon, Portugal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.